Enhanced glycemic control for preventing and treating diabetic neuropathy

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Little, Ann ^a   Feldman, Eva ^b   Hughes, Richard A C ^c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIBLIOGRAPHIC DATABASE; DATA ANALYSIS; DATA SYNTHESIS; DIABETIC NEUROPATHY; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INFORMATION PROCESSING; MEDIAN NERVE; MOTOR DYSFUNCTION; MOTOR NERVE CONDUCTION; MUSCLE ACTION POTENTIAL; NERVE CONDUCTION; NERVE POTENTIAL; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; PERONEUS NERVE; QUANTITATIVE ANALYSIS; RATING SCALE; REVIEW; SENSITIVITY ANALYSIS; SENSORY DYSFUNCTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ULNAR NERVE;

EID: 70249149999     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007543     Document Type: Review

References (13)

1. Boulton AJM, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabetes Medicine 1998;15(6):508-514 (Pubitemid 28261150)
2. Boulton AJM, Malik RA, Arezzo JC, Sosenko JM. Diabetic Somatic Neuropathies (Technical Review). Diabetes Care 2004;27(6):1458-1486
3. Brownlee M. The Pathobiology of Diabetic Complications. Diabetes 2005;54(6):1615-1625
4. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. NEJM 1993;329(14): 977-986
5. Dyck PJ. Severity and Staging of Diabetic Polyneuropathy. In: Gries FA, Cameron NE, Low PA, Ziegler D editor(s). Textbook of Diabetic Neuropathy. Stuttgart, Thieme, 2003:170-175
6. Dyck PJ, Hughes RAC, O'Brien PC. Quantitating overall neuropathic symptoms, impairments, and outcomes. In: Dyck PJ, Thomas PK, Eds editor(s). Peripheral Neuropathy. 4th Edition. Philadelphia: Elsevier Saunders, 2005:1038-1039
7. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-Up Report on the Diagnosis of Diabetes Mellitus. Diabetes Care 2003;26(11):3160-3167
8. Gale EAM. The Discovery of Type I Diabetes. Diabetes 2001;50(2): 217-226
9. Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
10. North-West Diabetes Foot Care Study. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabetic Medicine 2002;19(5):377-384
11. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent Diabetes Mellitus. New England Journal of Medicine 1995;333(1):89-94.
12. UK PDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352: 837-853 (Pubitemid 28416718)
13. Vinik AL, Maser RE, Mitchell BD, Freeman R. Diabetic Autonomic Neuropathy. Diabetes Care 2003;26(5):1553-1579